Opioid Ligands Having Delayed Long-Term Antagonist Activity: Potential Pharmacotherapies for Opioid Abuse

E-ISSN： 1875-5607|3|2|137-144

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.3, Iss.2, 2003-01, pp. : 137-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Kappa opioid agonists as targets for pharmacotherapies in cocaine abuse

By Neumeyer J.L. Mello N.K. Stevens Negus S. Bidlack J.M.

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 337-344

Elsevier

Access to resources Recommend Favorite

Opioid receptor polymorphismsand opioid abuse

By Lee Nancy M Smith Andrew P

Pharmacogenomics, Vol. 3, Iss. 2, 2002-03 ,pp. : 219-227

Future Medicine

Access to resources Recommend Favorite

Effect of the tyramine fragment of opioid receptor ligands on their agonist and antagonist properties

By Kuz’mina N. Osipova E. Kuz’min V. Sitnikov V.

Pharmaceutical Chemistry Journal, Vol. 40, Iss. 5, 2006-05 ,pp. : 254-260

Springer Publishing Company

Access to resources Recommend Favorite

Effects of -opioid receptor agonists on long-term cocaine use and dopamine neurotransmission

By Collins S.L. D'Addario C. Izenwasser S.

European Journal of Pharmacology, Vol. 426, Iss. 1, 2001-08 ,pp. : 25-34

Elsevier

Access to resources Recommend Favorite

14 -Chlorocinnamoylamino derivatives of metopon: long-term -opioid receptor antagonists

By McLaughlin J.P. Sebastian A. Archer S. Bidlack J.M.

European Journal of Pharmacology, Vol. 320, Iss. 2, 1997-02 ,pp. : 121-129

Elsevier

Access to resources Recommend Favorite